Zynerba Pharmaceuticals Inc
(NASDAQ : ZYNE)

( )
ZYNE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MNKMallinckrodt Plc
1.58%34.6821.1%$126.04m
PRGOPerrigo Co. Plc
3.64%72.966.7%$115.08m
SHPGShire PLC Sponsored ADR
-0.63%170.420.4%$114.29m
ENDPEndo International Plc
-1.94%15.648.9%$89.03m
JAZZJazz Pharmaceuticals Plc
0.40%173.812.2%$72.23m
ICPTIntercept Pharmaceuticals, Inc.
0.20%103.4218.7%$68.63m
SAGESAGE Therapeutics, Inc.
2.03%152.089.6%$57.16m
UTHRUnited Therapeutics Corporation
-2.97%125.6114.4%$50.56m
CTLTCatalent Inc
0.39%40.942.6%$47.83m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.59%136.066.8%$43.22m
PTLAPortola Pharmaceuticals, Inc.
0.04%25.597.7%$40.54m
SUPNSupernus Pharmaceuticals, Inc.
2.99%44.806.2%$40.22m
ICLRICON Plc
0.23%143.684.2%$39.99m
ZGNXZogenix, Inc.
1.15%48.6011.9%$37.44m
HZNPHorizon Pharma plc
-0.15%20.577.5%$32.74m

Company Profile

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.